X-84469012-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_001177479.2(HDX):c.711C>T(p.Gly237=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00245 in 1,209,508 control chromosomes in the GnomAD database, including 59 homozygotes. There are 758 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.013 ( 35 hom., 383 hem., cov: 23)
Exomes 𝑓: 0.0013 ( 24 hom. 375 hem. )
Consequence
HDX
NM_001177479.2 synonymous
NM_001177479.2 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.670
Genes affected
HDX (HGNC:26411): (highly divergent homeobox) Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be located in nucleus. Predicted to be part of chromatin. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BP6
Variant X-84469012-G-A is Benign according to our data. Variant chrX-84469012-G-A is described in ClinVar as [Benign]. Clinvar id is 777795.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.67 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.0133 (1485/111714) while in subpopulation AFR AF= 0.047 (1441/30682). AF 95% confidence interval is 0.0449. There are 35 homozygotes in gnomad4. There are 383 alleles in male gnomad4 subpopulation. Median coverage is 23. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 35 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
HDX | NM_001177479.2 | c.711C>T | p.Gly237= | synonymous_variant | 4/11 | ENST00000373177.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
HDX | ENST00000373177.3 | c.711C>T | p.Gly237= | synonymous_variant | 4/11 | 1 | NM_001177479.2 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0133 AC: 1480AN: 111663Hom.: 35 Cov.: 23 AF XY: 0.0112 AC XY: 379AN XY: 33873
GnomAD3 genomes
AF:
AC:
1480
AN:
111663
Hom.:
Cov.:
23
AF XY:
AC XY:
379
AN XY:
33873
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00391 AC: 718AN: 183408Hom.: 11 AF XY: 0.00280 AC XY: 190AN XY: 67858
GnomAD3 exomes
AF:
AC:
718
AN:
183408
Hom.:
AF XY:
AC XY:
190
AN XY:
67858
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00135 AC: 1482AN: 1097794Hom.: 24 Cov.: 31 AF XY: 0.00103 AC XY: 375AN XY: 363150
GnomAD4 exome
AF:
AC:
1482
AN:
1097794
Hom.:
Cov.:
31
AF XY:
AC XY:
375
AN XY:
363150
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0133 AC: 1485AN: 111714Hom.: 35 Cov.: 23 AF XY: 0.0113 AC XY: 383AN XY: 33934
GnomAD4 genome
AF:
AC:
1485
AN:
111714
Hom.:
Cov.:
23
AF XY:
AC XY:
383
AN XY:
33934
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Apr 16, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at